The human beta-defensin-3, an antibacterial peptide with multiple biological functions.

A group of interesting molecules called defensins exhibit multiple functions but have been primarily recognized to possess a broad spectrum of antimicrobial activities. Studies have reported two different types of defensins (alpha and beta) from human and animals, a cyclic theta defensin from rhesus, and several defensin-like peptides from plants. There is no amino acid sequence homology between these peptides, but they all contain three Cys-Cys disulfide linkages while the connectivities are different. Human beta-defensin-3 (HbetaD-3) is the most recently discovered member of the host-defense peptide family that has attracted much attention. This molecule is expressed either constitutively or induced upon a challenge, and a growing evidence indicates the involvement of such molecules in adaptive immunity as well. It has been shown to exhibit antibacterial activities towards Gram-negative and Gram-positive bacteria as well as an ability to act as a chemo-attractant. Analysis of NMR structural data suggested a symmetrical dimeric form of this peptide in solution, which consists of three beta strands and a short helix in the N-terminal region. While the disulfide linkages are known to provide the structural stability and stability against proteases, the biological relevance of this dimeric form was contradicted by another biological study. Since there is considerable current interest in developing HbetaD-3 for possible pharmaceutical applications, studies to further our understanding on the determinants of antibacterial activities and immunomodulatory function of HbetaD-3 are considered to be highly significant. The knowledge of its biosynthetic regulation will also help in understanding the role of HbetaD-3 in immunity. This article presents an overview of the expression and regulation of HbetaD-3 in humans, and the structure-function correlations among HbetaD-3 and its modified peptides are discussed emphasizing the functional importance. The future scope for studies on HbetaD-3 and design of short potent antimicrobial peptides, based on the native HbetaD-3 molecule, that do not interfere in the immunomodulatory function is also outlined.

[1]  D. Hoover,et al.  The Structure of Human Macrophage Inflammatory Protein-3α/CCL20 , 2002, The Journal of Biological Chemistry.

[2]  K. Adermann,et al.  Engineering disulfide bonds of the novel human β‐defensins hBD‐27 and hBD‐28: Differences in disulfide formation and biological activity among human β‐defensins , 2005, Biopolymers.

[3]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[4]  C. Vogelmeier,et al.  Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. , 2001, Cell and tissue research.

[5]  D. Hoover,et al.  The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. , 2001, The Journal of biological chemistry.

[6]  A. Waring,et al.  Membrane-disruptive abilities of beta-hairpin antimicrobial peptides correlate with conformation and activity: a 31P and 1H NMR study. , 2005, Biochimica et biophysica acta.

[7]  A. Amoroso,et al.  A study of host defence peptide β-defensin 3 in primates , 2003 .

[8]  P. McCray,et al.  Expression and Activity of β-Defensins and LL-37 in the Developing Human Lung1 , 2005, The Journal of Immunology.

[9]  W. Florio,et al.  In Vitro Bactericidal Activity of Human β-Defensin 3 against Multidrug-Resistant Nosocomial Strains , 2006, Antimicrobial Agents and Chemotherapy.

[10]  S. Lovas,et al.  The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.

[11]  Alessandro Tossi,et al.  Amphipathic, α‐helical antimicrobial peptides , 2000 .

[12]  Y. Shai.  From innate immunity to de-novo designed antimicrobial peptides. , 2002, Current pharmaceutical design.

[13]  Jesse D. Walters,et al.  Erratum: Discovery of five conserved β-defensin gene clusters using a computational search strategy (Proceedings of the National Academy of Sciences of the United States of America (February 19, 2002) 99 (2129-2133)) , 2002 .

[14]  Dong-Kuk Lee,et al.  Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. , 2003, Biochemistry.

[15]  Jufang Wang,et al.  Production of Bioactive Human β-defensin-3 in Escherichia coli by Soluble Fusion Expression , 2006, Biotechnology Letters.

[16]  A. Ramamoorthy,et al.  An innovative procedure using a sublimable solid to align lipid bilayers for solid-state NMR studies. , 2002, Biophysical journal.

[17]  Á. Zaballos,et al.  NMR Solution Structure of Murine CCL20/MIP-3α, a Chemokine That Specifically Chemoattracts Immature Dendritic Cells and Lymphocytes through Its Highly Specific Interaction with the β-Chemokine Receptor CCR6* , 2001, The Journal of Biological Chemistry.

[18]  H. Heng,et al.  Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. , 1998, Gene.

[19]  Jacek Lubkowski,et al.  Antimicrobial Characterization of Human β-Defensin 3 Derivatives , 2003, Antimicrobial Agents and Chemotherapy.

[20]  A. Pardi,et al.  NMR studies of defensin antimicrobial peptides. 1. Resonance assignment and secondary structure determination of rabbit NP-2 and human HNP-1. , 1992, Biochemistry.

[21]  H. Vogel,et al.  The Solution Structures of the Human β-Defensins Lead to a Better Understanding of the Potent Bactericidal Activity of HBD3 against Staphylococcus aureus * , 2002, The Journal of Biological Chemistry.

[22]  Ji Ming Wang,et al.  β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .

[23]  C. Bevins,et al.  Mechanisms of Disease: defensins in gastrointestinal diseases , 2005, Nature Clinical Practice Gastroenterology &Hepatology.

[24]  Friedrich Paulsen,et al.  Human beta-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors. , 2005, Arthritis and rheumatism.

[25]  M. Boniotto,et al.  Primate β-defensins - Structure, Function and Evolution , 2005 .

[26]  Frances Separovic,et al.  Interaction of antimicrobial peptides from Australian amphibians with lipid membranes. , 2003, Chemistry and physics of lipids.

[27]  R. Hancock,et al.  Interaction of Cationic Peptides with Lipoteichoic Acid and Gram-Positive Bacteria , 1999, Infection and Immunity.

[28]  R. Levine,et al.  Inactivation of Human β-Defensins 2 and 3 by Elastolytic Cathepsins1 , 2003, The Journal of Immunology.

[29]  M. Raida,et al.  hBD-1: a novel beta-defensin from human plasma. , 1995, FEBS letters.

[30]  H. Critchley,et al.  Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. , 2003, Journal of reproductive immunology.

[31]  R. Blumenthal,et al.  Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection , 2005, Journal of Virology.

[32]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[33]  R. Bals,et al.  Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  P. Nibbering,et al.  Inhibition of hBD-3, but not hBD-1 and hBD-2, mRNA expression by corticosteroids. , 2001, Biochemical and biophysical research communications.

[35]  Alessandro Tossi,et al.  Mammalian defensins: structures and mechanism of antibiotic activity , 2005, Journal of leukocyte biology.

[36]  R. Hancock,et al.  Antiendotoxin activity of cationic peptide antimicrobial agents , 1996, Infection and immunity.

[37]  R. Hancock,et al.  The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.

[38]  J. Schröder,et al.  Human beta-defensin-2. , 1999, The international journal of biochemistry & cell biology.

[39]  S. Straus,et al.  Interaction of alamethicin with ether-linked phospholipid bilayers: oriented circular dichroism, 31P solid-state NMR, and differential scanning calorimetry studies. , 2005, Biophysical journal.

[40]  J. Egozcue.  [The cloning]. , 1998, Medicina clinica.

[41]  T. Ganz,et al.  A 450-kb contig of defensin genes on human chromosome 8p23. , 1999, Gene.

[42]  R. Hancock,et al.  Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification , 1994, Antimicrobial Agents and Chemotherapy.

[43]  R. Hancock,et al.  Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein1 , 2000, The Journal of Immunology.

[44]  W. Maloy,et al.  Structure–activity studies on magainins and other host defense peptides , 1995, Biopolymers.

[45]  M. Lederman,et al.  Role of Human β-defensins in HIV Infection , 2006, Advances in dental research.

[46]  W. Guggino.  Cystic Fibrosis and the Salt Controversy , 1999, Cell.

[47]  A. Pardi,et al.  Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. , 1995, Biochemistry.

[48]  R. Hancock.  Peptide antibiotics , 1997, The Lancet.

[49]  Nick C. Polfer,et al.  Structure-Activity Relationships in Defensin Dimers , 2004, Journal of Biological Chemistry.

[50]  A. Hoeft,et al.  Screening of copy number polymorphisms in human beta-defensin genes using modified real-time quantitative PCR. , 2006, Journal of immunological methods.

[51]  H V Westerhoff,et al.  Magainins and the disruption of membrane-linked free-energy transduction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Taub,et al.  Identification of Defensin-1, Defensin-2, and CAP37/Azurocidin as T-cell Chemoattractant Proteins Released from Interleukin-8-stimulated Neutrophils (*) , 1996, The Journal of Biological Chemistry.

[53]  A. Rao,et al.  Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. , 1999, Archives of biochemistry and biophysics.

[54]  T. Ganz,et al.  Differential Regulation of β-Defensin Expression in Human Skin by Microbial Stimuli1 , 2005, The Journal of Immunology.

[55]  V. Shanmuganathan,et al.  The spectrum of antimicrobial peptide expression at the ocular surface. , 2005, Investigative ophthalmology & visual science.

[56]  L. Schwichtenberg,et al.  Mucoid Pseudomonas aeruginosa, TNF- α , and IL-1 β , but Not IL-6, Induce Human β -Defensin-2 in Respiratory Epithelia , 2000 .

[57]  W. Coulter,et al.  Induction of β-Defensin Resistance in the Oral Anaerobe Porphyromonas gingivalis , 2005, Antimicrobial Agents and Chemotherapy.

[58]  L. Samaranayake,et al.  Expression of human β-defensin-3 in gingival epithelia , 2005 .

[59]  M. Schmid,et al.  Chronisch-entzündliche Darmerkrankungen (CED): Neue pathophysiologische Erkenntnisse – Folgerungen für die Klinik , 2005 .

[60]  M. Lederman,et al.  Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. , 2003, AIDS.

[61]  J. Womack,et al.  High-resolution FISH mapping of beta-defensin genes to river buffalo and sheep chromosomes suggests a chromosome discrepancy in ffttle standard karyotypes. , 1996, Cytogenetics and Cell Genetics.

[62]  W. Florio,et al.  Susceptibility of Streptococcusmutans and Actinobacillusactinomycetemcomitans to Bactericidal Activity of Human β-Defensin 3 in Biological Fluids , 2005, Antimicrobial Agents and Chemotherapy.

[63]  H. Heng,et al.  The human β-defensin-1 and α-defensins are encoded by adjacent genes : Two peptide families with differing disulfide topology share a common ancestry , 1997 .

[64]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[65]  Robert Bals,et al.  Epithelial antimicrobial peptides in host defense against infection , 2000, Respiratory research.

[66]  Huey W. Huang,et al.  Action of antimicrobial peptides: two-state model. , 2000, Biochemistry.

[67]  D. Eisenberg,et al.  Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. , 1991, Science.

[68]  D. Hoover,et al.  Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[69]  D. S. McVey,et al.  F peptide . proline-arginine-rich neutrophil antimicrobial ( PR-26 ) derived from PR-39 , a Antibacterial activity of a synthetic peptide , 1995 .

[70]  R. Siebert,et al.  Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. , 1997, Genomics.

[71]  G. K. Johnson,et al.  Discovery of new human β-defensins using a genomics-based approach , 2001 .

[72]  M. Lederman,et al.  Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication , 2003 .

[73]  C. Bevins,et al.  Antimicrobial Peptides as Mediators of Epithelial Host Defense , 1999, Pediatric Research.

[74]  T. Ganz,et al.  The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. , 2001, Biochemistry.

[75]  E. Greenberg,et al.  Production of β-defensins by human airway epithelia , 1998 .

[76]  N. Fujii,et al.  An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.

[77]  M. B. Banaszak Holl,et al.  Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. , 2005, Biophysical journal.

[78]  R. Hancock,et al.  Solution structure and interaction of the antimicrobial polyphemusins with lipid membranes. , 2005, Biochemistry.

[79]  K. Fellermann,et al.  [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance]. , 2005, Praxis.

[80]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[81]  H. Critchley,et al.  Innate immune defences in the human endometrium , 2003, Reproductive biology and endocrinology : RB&E.

[82]  H. Sticht,et al.  Structure determination of human and murine β‐defensins reveals structural conservation in the absence of significant sequence similarity , 2001, Protein science : a publication of the Protein Society.

[83]  G. K. Johnson,et al.  Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. , 2005, Molecular immunology.

[84]  R. Hancock,et al.  Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides , 1999, Infection and Immunity.

[85]  M. Kagnoff,et al.  Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. , 1999, Journal of immunology.

[86]  S. Krisanaprakornkit,et al.  Expression of the Peptide Antibiotic Human β-Defensin 1 in Cultured Gingival Epithelial Cells and Gingival Tissue , 1998, Infection and Immunity.

[87]  Wuyuan Lu,et al.  Antibacterial Activity and Specificity of the Six Human α-Defensins , 2005, Antimicrobial Agents and Chemotherapy.

[88]  B. Wren,et al.  Intestinal Innate Immunity to Campylobacter jejuni Results in Induction of Bactericidal Human Beta-Defensins 2 and 3 , 2005, Infection and Immunity.

[89]  R. Siebert,et al.  The novel human beta-defensin-3 is widely expressed in oral tissues. , 2002, European journal of oral sciences.

[90]  M. Selsted,et al.  Mammalian defensins in the antimicrobial immune response , 2005, Nature Immunology.

[91]  Y. Shai,et al.  Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .

[92]  A. Waring,et al.  Solid-state NMR investigation of the selective disruption of lipid membranes by protegrin-1. , 2004, Biochemistry.

[93]  A. Lumsden,et al.  Defensins and cathelicidins: Neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis , 2005, Journal of cellular and molecular medicine.

[94]  I. Nagaoka,et al.  The Human β-Defensins (-1, -2, -3, -4) and Cathelicidin LL-37 Induce IL-18 Secretion through p38 and ERK MAPK Activation in Primary Human Keratinocytes1 , 2005, The Journal of Immunology.

[95]  P. Lachmann,et al.  Inhibition of antimicrobial peptides by group A streptococci: SIC and DRS. , 2006, Biochemical Society transactions.

[96]  L. Kwak,et al.  Roles of antimicrobial peptides such as defensins in innate and adaptive immunity , 2003, Annals of the rheumatic diseases.

[97]  K. Reddy,et al.  Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics – a mini review , 2005, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[98]  N. Fujii,et al.  Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. , 1995, Biochemistry.

[99]  D. Hoover,et al.  Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. , 2004, Annual review of immunology.

[100]  Ayyalusamy Ramamoorthy,et al.  Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding. , 2006, Biochemistry.

[101]  R. B. Merrifield,et al.  Antibacterial and antimalarial properties of peptides that are cecropin‐melittin hybrids , 1989, FEBS letters.

[102]  Enno Klüver,et al.  Synthesis and structure–activity relationship of β‐defensins, multi‐functional peptides of the immune system , 2006, Journal of peptide science : an official publication of the European Peptide Society.

[103]  Jiang Hong,et al.  A Repertoire of Novel Antibacterial Diastereomeric Peptides with Selective Cytolytic Activity* , 1997, The Journal of Biological Chemistry.

[104]  Y. Ouchi,et al.  Identification of Multiple Novel Epididymis-Specific β-Defensin Isoforms in Humans and Mice1 , 2002, The Journal of Immunology.

[105]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[106]  O. Chertov,et al.  Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells , 2000, Journal of leukocyte biology.

[107]  J. Schröder,et al.  Psoriatic scales: a promising source for the isolation of human skin‐derived antimicrobial proteins , 2005, Journal of leukocyte biology.

[108]  Anna Karlsson,et al.  Interleukin-8-Derived Peptide Has Antibacterial Activity , 2005, Antimicrobial Agents and Chemotherapy.

[109]  K. Matsuzaki.  Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.

[110]  S. White,et al.  Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores , 1994, Protein science : a publication of the Protein Society.

[111]  W. Falk,et al.  A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. , 1980, Journal of immunological methods.

[112]  R. Hancock,et al.  Biological properties of structurally related alpha-helical cationic antimicrobial peptides. , 1999, Infection and immunity.

[113]  A. Pardi,et al.  NMR studies of defensin antimicrobial peptides. 2. Three-dimensional structures of rabbit NP-2 and human HNP-1. , 1992, Biochemistry.

[114]  A. Dutra,et al.  Human enteric defensin genes: chromosomal map position and a model for possible evolutionary relationships. , 1996, Genomics.

[115]  U. Seydel,et al.  Lipid-Specific Membrane Activity of Human β-Defensin-3† , 2006 .

[116]  P. Barnes,et al.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.

[117]  K. Fellermann,et al.  Defensins – innate immunity at the epithelial frontier , 2001, European journal of gastroenterology & hepatology.

[118]  J. R. McMillan,et al.  Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection , 2005, Gene Therapy.

[119]  Robert E W Hancock,et al.  Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index* , 2005, Journal of Biological Chemistry.

[120]  D. Andreu,et al.  Animal antimicrobial peptides: an overview. , 1998, Biopolymers.

[121]  R. Epand,et al.  Membrane lipid composition and the interaction of pardaxin: the role of cholesterol. , 2006, Protein and peptide letters.

[122]  A. Ulrich,et al.  NMR methods for studying membrane‐active antimicrobial peptides , 2004 .

[123]  Robert Blumenthal,et al.  The Structure of Human β-Defensin-2 Shows Evidence of Higher Order Oligomerization* , 2000, The Journal of Biological Chemistry.

[124]  Alessandro Tossi,et al.  Amphipathic α helical antimicrobial peptides. , 2001 .

[125]  B. Bechinger.  Detergent-like properties of magainin antibiotic peptides: a 31P solid-state NMR spectroscopy study. , 2005, Biochimica et biophysica acta.

[126]  T. Ganz,et al.  The NMR Structure of Human β-Defensin-2 Reveals a Novel α-Helical Segment†,‡ , 2001 .

[127]  M. Yeaman,et al.  Structural congruence among membrane-active host defense polypeptides of diverse phylogeny. , 2006, Biochimica et biophysica acta.

[128]  V. Bafna,et al.  Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. , 1998, The Journal of clinical investigation.

[129]  S. Krisanaprakornkit,et al.  Defensin antimicrobial peptides in the oral cavity. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[130]  Shadi Abu-Baker,et al.  Structural changes in a binary mixed phospholipid bilayer of DOPG and DOPS upon saposin C interaction at acidic pH utilizing 31P and 2H solid-state NMR spectroscopy. , 2005, Biochimica et biophysica acta.

[131]  Y. Shai,et al.  Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.

[132]  M. Dathe,et al.  Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. , 1999, Biochimica et biophysica acta.

[133]  M. Ghannoum,et al.  Human Beta-defensins: Differential Activity against Candidal Species and Regulation by Candida albicans , 2005, Journal of dental research.

[134]  F. Ruddle,et al.  Localization of the cryptdin locus on mouse chromosome 8. , 1989, Genomics.

[135]  P. Lachmann,et al.  Attribution of the Various Inhibitory Actions of the Streptococcal Inhibitor of Complement (SIC) to Regions within the Molecule* , 2005, Journal of Biological Chemistry.

[136]  S. Nuding,et al.  A flow cytometric assay to monitor antimicrobial activity of defensins and cationic tissue extracts. , 2006, Journal of microbiological methods.

[137]  M. Selsted,et al.  Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils. , 1993, The Journal of biological chemistry.

[138]  P. McCray,et al.  β-Defensins in Lung Host Defense , 2002 .

[139]  Roland Contreras,et al.  Human Antimicrobial Peptides: Defensins, Cathelicidins and Histatins , 2005, Biotechnology Letters.

[140]  Rainer Hedrich,et al.  Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity , 2001, Cell and Tissue Research.

[141]  E. Palmer.  Shc: a dominant player after ten seasons , 2002, Nature Immunology.

[142]  B. Meyer,et al.  Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. , 2005, Biochemistry.

[143]  H. Sahl,et al.  Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes , 1985, Archives of Microbiology.